Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Conditions
- Poorly Differentiated Thyroid Gland Carcinoma
- Recurrent Thyroid Gland Carcinoma
- Stage I Thyroid Gland Follicular Carcinoma
- Stage I Thyroid Gland Papillary Carcinoma
- Stage II Thyroid Gland Follicular Carcinoma
- Stage II Thyroid Gland Papillary Carcinoma
- Stage III Thyroid Gland Follicular Carcinoma
- Stage III Thyroid Gland Papillary Carcinoma
- Stage IVA Thyroid Gland Follicular Carcinoma
- Stage IVA Thyroid Gland Papillary Carcinoma
- Stage IVB Thyroid Gland Follicular Carcinoma
- Stage IVB Thyroid Gland Papillary Carcinoma
- Stage IVC Thyroid Gland Follicular Carcinoma
- Stage IVC Thyroid Gland Papillary Carcinoma
- Tall Cell Variant Thyroid Gland Papillary Carcinoma
- Thyroid Gland Oncocytic Follicular Carcinoma
Interventions
- DRUG: Cabozantinib S-malate
- OTHER: Laboratory Biomarker Analysis
Sponsor
National Cancer Institute (NCI)
Collaborators